Glassman Wealth Services’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-1,272
| Closed | -$675K | – | 1661 |
|
|
2023
Q4 | $675K | Sell |
1,272
-68
| -5% | -$32.9K | 0.1% | 65 |
|
|
2023
Q3 | $678K | Sell |
1,340
-6
| -0.4% | -$3.2K | 0.11% | 58 |
|
|
2023
Q2 | $702K | Sell |
1,346
-30
| -2% | -$16.2K | 0.11% | 53 |
|
|
2023
Q1 | $793K | Buy |
1,376
+33
| +2% | +$18.6K | 0.14% | 48 |
|
|
2022
Q4 | $740K | Buy |
1,343
+16
| +1% | +$8.48K | 0.14% | 51 |
|
|
2022
Q3 | $673K | Buy |
1,327
+4
| +0.3% | +$2.24K | 0.14% | 48 |
|
|
2022
Q2 | $719K | Buy |
1,323
+56
| +4% | +$30.8K | 0.15% | 49 |
|
|
2022
Q1 | $748K | Buy |
1,267
+62
| +5% | +$35.6K | 0.14% | 57 |
|
|
2021
Q4 | $804K | Buy |
1,205
+136
| +13% | +$84.9K | 0.15% | 52 |
|
|
2021
Q3 | $611K | Buy |
1,069
+62
| +6% | +$34K | 0.13% | 70 |
|
|
2021
Q2 | $508K | Buy |
1,007
+34
| +3% | +$16K | 0.11% | 75 |
|
|
2021
Q1 | $444K | Buy |
973
+2
| +0.2% | +$955 | 0.09% | 86 |
|
|
2020
Q4 | $452K | Buy |
971
+17
| +2% | +$7.97K | 0.1% | 84 |
|
|
2020
Q3 | $421K | Sell |
954
-74
| -7% | -$30.6K | 0.12% | 76 |
|
|
2020
Q2 | $373K | Buy |
1,028
+3
| +0.3% | +$1.01K | 0.12% | 84 |
|
|
2020
Q1 | $291K | Sell |
1,025
-64
| -6% | -$20.2K | 0.11% | 83 |
|
|
2019
Q4 | $354K | Buy |
1,089
+92
| +9% | +$27.9K | 0.13% | 83 |
|
|
2019
Q3 | $290K | Sell |
997
-5
| -0.5% | -$1.43K | 0.12% | 89 |
|
|
2019
Q2 | $294K | Buy |
1,002
+15
| +2% | +$4.13K | 0.12% | 87 |
|
|
2019
Q1 | $270K | Buy |
987
+86
| +10% | +$21.4K | 0.12% | 92 |
|
|
2018
Q4 | $202K | Buy |
901
+3
| +0.3% | +$704 | 0.11% | 99 |
|
|
2018
Q3 | $219K | Sell |
898
-66
| -7% | -$15.2K | 0.1% | 99 |
|
|
2018
Q2 | $200K | Buy |
964
+8
| +0.8% | +$1.7K | 0.1% | 88 |
|
|
2018
Q1 | $197K | Buy |
956
+54
| +6% | +$11.3K | 0.12% | 79 |
|
|
2017
Q4 | $171K | Hold |
902
| – | – | 0.1% | 85 |
|
|
2017
Q3 | $171K | Sell |
902
-137
| -13% | -$24.8K | 0.11% | 85 |
|
|
2017
Q2 | $181K | Buy |
1,039
+195
| +23% | +$32.8K | 0.12% | 84 |
|
|
2017
Q1 | $130K | Hold |
844
| – | – | 0.09% | 100 |
|
|
2016
Q4 | $119K | Hold |
844
| – | – | 0.08% | 120 |
|
|
2016
Q3 | $134K | Hold |
844
| – | – | 0.11% | 87 |
|
|
2016
Q2 | $125K | Hold |
844
| – | – | 0.11% | 85 |
|
|
2016
Q1 | $120K | Hold |
844
| – | – | 0.11% | 96 |
|
|
2015
Q4 | $120K | Hold |
844
| – | – | 0.11% | 103 |
|
|
2015
Q3 | $103K | Hold |
844
| – | – | 0.09% | 102 |
|
|
2015
Q2 | $110K | Hold |
844
| – | – | 0.09% | 105 |
|
|
2015
Q1 | $113K | Hold |
844
| – | – | 0.09% | 104 |
|
|
2014
Q4 | $106K | Buy |
+844
| New | +$103K | 0.08% | 115 |
|
Other funds holding TMO
Glassman Wealth Services's TMO Position: Q1 2024 in Review
Glassman Wealth Services sold out of Thermo Fisher Scientific (TMO) in Q1 2024, closing a stake of 1,272 shares — an estimated $675K sold.
Glassman Wealth Services first reported a position in TMO in Q4 2014 and held it in 37 quarters. The position peaked at $804K in Q4 2021. 2,527 funds tracked by Wall St. Rank hold TMO as of Q1 2024.
- Glassman Wealth Services reported no remaining Thermo Fisher Scientific position as of Q1 2024 after selling out during the quarter.
- Glassman Wealth Services sold 1,272 Thermo Fisher Scientific shares in Q1 2024, an estimated $675K.
- Glassman Wealth Services first reported a position in Thermo Fisher Scientific in Q4 2014 and held it in 37 quarters.
- Glassman Wealth Services's Thermo Fisher Scientific position peaked at $804K in Q4 2021.
- 2,527 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2024.
Based on Glassman Wealth Services's 13F filing for Q1 2024, filed 3 May 2024.